FMCG Gurus highlights opportunities for targeting brain health with plant-based omega-3 ingredients
Consumers associate omega-3s with cognitive health. They are also interested in plant-based alternatives, creating opportunities for plant-based omega-3 sources.
Photo © iStockphoto.com/Tina_Rencelj
According to FMCG Gurus, brain health is a priority for consumers irrespective demographic. The market researcher cites 2023 research showing 48% of consumers intend to maintain and improve their brain health over the next 12 months. Similarly, 29% of respondents find claims about the maintenance of normal brain function appealing. What does good cognitive function look like? Well, according to FMCG, 59% of consumers cite good memory levels, and 48% say being able to concentrate for a significant period of time are indicators of good cognitive function. These are two common issues and represent areas of opportunity for manufacturers.
When it comes to ingredients, FMCG says that omega-3 products are among the most well-recognized and trusted. Its research shows that 92% of global consumers in 2022 said that they have heard of omega-3s and of these consumers, 64% associated them with supporting cognitive health. Fish is the most recognizable source of omega-3 for consumers but as 48% of global consumers say they are avoiding or moderating their consumption of animal-based products, there is an opportunity to educate consumers about efficacy of alternative sources of omega-3 such as algae, particularly for the support of cognitive function.
If you want to learn more, FMCG Gurus will be hosting two interactive roundtable discussions dedicated to plant-based omega-3s in the cognitive health category:
•28th September 2023
•03:00 PM BST / 10:00 AM ET
•27th September 2023
•08:00 AM BST / 03:00 PM SGT
The events are hosted by FMCG and FrieslandCampina Ingredients, in collaboration with GOED.
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
